Articles Posted May 2013

  • Ranbaxy inks record-setting $500M manufacturing settlement

      Ranbaxy Laboratories made history . The India-based generics maker pleaded guilty to U.S. drug safety violations and agreed to pay $500 million in penalties, in the largest-ever federal settlement with a maker of copycat drugs. Ranbaxy pleaded guilty to three felony counts of violating drug-safety laws and four felony counts of making false statements […]